PFG
XPH icon

Piershale Financial Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Piershale Financial Group’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-332
Closed -$21K – 171
2015
Q2 		$21K Hold
332
– – 0.02% 51
2015
Q1 		$20K Buy
332
+70
+27% +$4.15K 0.02% 56
2014
Q4 		$14K Sell
262
-88
-25% -$4.81K 0.01% 87
2014
Q3 		$19K Buy
+350
New +$17.8K 0.02% 63

Other funds holding XPH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
HF
Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

Piershale Financial Group's XPH Position: Q3 2015 in Review

Piershale Financial Group sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2015, closing a stake of 332 shares — an estimated $21K sold.

Piershale Financial Group first reported a position in XPH in Q3 2014 and held it in 4 quarters. The position peaked at $21K in Q2 2015. 77 funds tracked by Wall St. Rank hold XPH as of Q3 2015.

  • Piershale Financial Group reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
  • Piershale Financial Group sold 332 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2015, an estimated $21K.
  • Piershale Financial Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2014 and held it in 4 quarters.
  • Piershale Financial Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $21K in Q2 2015.
  • 77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2015.

Based on Piershale Financial Group's 13F filing for Q3 2015, filed 27 Oct 2015.